Antidiabetic Drug May Reduce Colorectal Cancer Incidence
Case Western Reserve University
Colorectal cancer is the second-leading cause of cancer mortality with 52,550 deaths per year
Immunology
World-First Human Trial Offers New Type 1 Diabetes Treatment
St Vincent’s Institute of Medical Research
A commonly prescribed rheumatoid arthritis drug may suppress the progression of type 1 diabetes
Protein “Barcodes” Can Precisely Guide CAR T Cells to Targets
Children's Hospital of Philadelphia
Identifying peptide backbones that link protein complexes to cancer cells can help maximize CAR therapy applicability to different tumor types
Targeting Viral Protein May Reduce HIV-Related Comorbidities
University of Montreal Hospital Research Centre
Per the WHO records, more than 39 million people were living with HIV at the end of 2022
The Power of Vendor–Laboratory Partnerships
Miriam Bergeret, MSc
Geisinger Medical Center’s immunology laboratory recently maximized their workflows through a vital partnership with Thermo Fisher Scientific
Measles Remains a Global Threat as Vaccination Coverage Declines
Centers for Disease Control and Prevention
Millions of children missed vaccinations during the COVID-19 pandemic, driving up the global number of cases
Gender-Neutral Vaccination Prevents Oncogenic HPV Most Effectively
Karolinska Institutet
Vaccinating boys and girls induces herd immunity that helps eradicate oncogenic HPV types more quickly
Adjuvanted Recombinant COVID-19 Vaccine Outperforms Competitors
Korea University
The GB510/AS03 vaccine elicits a stronger antibody immune response against the ancestral SARS-CoV-2 strain than ChAdOx1-S
ACS Updates Lung Cancer Screening Guideline
American Cancer Society
The Society aims to reduce lung cancer deaths with updated screening recommendations
Health Data Help Better Predict RSV Infection Risk in Children
University of Helsinki
New study identifies children who would benefit most from new RSV prevention measures
Liver Cancer Adjuvant Immunotherapy Improved Survival in Phase 3 Trial
National Cancer Centre Singapore
Some 70–90 percent of patients with hepatocellular carcinoma experience cancer recurrence after curative treatment
CAR T-Cell Therapy Shows Race-Agnostic Response in MM Patients
American Society of Hematology
Multiple myeloma patients treated with CAR T-cell therapy showed similar survival outcomes regardless of race or ethnicity
Bispecific Cancer Drug Performs Well in Early Clinical Trial
University of Pittsburgh
Tebotelimab targets two proteins on tumor cells and drives specific immune response safely and effectively
Gene Therapy for Glioblastoma Shows Promise in Phase 1 Trial
Brigham and Women's Hospital
In a first-in-human trial in patients with recurrent glioblastoma, an oncolytic virus treatment safely extended survival
WHO Launches Comprehensive Web-Based TB Screening Tool
World Health Organization
ScreenTB is free for all to use and could help countries track and monitor TB’s spread
Decolonization with Mupirocin Prevents MRSA, ICU Infections
HCA Healthcare
Large clinical trial highlights the effect of nasal ointment on S. aureus infection and antibiotic resistance
FDA Authorizes “Updated” Novavax COVID-19 Vaccine
U.S. Food and Drug Administration
Improved vaccine includes Omicron variant’s spike protein and can offer enhanced protection in the 2023–2024 flu season
SARS-CoV-2 Can Infect Arteries and Worsen Plaque Inflammation
National Institutes of Health
Latest study explores the link between COVID-19 infection and increased risk of cardiovascular disease and stroke
New Sepsis Test Could Save Lives and Costs in Hospitals
Penn State
The test may prevent clinicians from relying solely on their judgement to treat a patient presenting sepsis symptoms
Trial Testing Immune Modulation in COVID-19 Patients Begins
National Institutes of Health
The therapeutic may prevent overactive immune systems from causing severe COVID-19-related illness